| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | Murray Dallan | Chief Customer Officer | May 02, 2024 | Sale | $140.00 | 3,635 | 508,900 | 18,125 | May 06, 2024, 08:09 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Mar 08, 2024 | Option Exercise | $13.90 | 15,000 | 208,500 | 37,840 | Mar 11, 2024, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Mar 08, 2024 | Sale | $123.25 | 15,000 | 1,848,795 | 34,685 | Mar 11, 2024, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Mar 07, 2024 | Option Exercise | $120.49 | 506 | 60,968 | 25,694 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Mar 08, 2024 | Option Exercise | $123.14 | 472 | 58,122 | 25,222 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 07, 2024 | Option Exercise | $120.49 | 512 | 61,691 | 68,982 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 08, 2024 | Option Exercise | $123.14 | 909 | 111,934 | 68,073 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Boor Kathryn Jean | Director | Mar 11, 2024 | Sale | $122.93 | 761 | 93,550 | 7,516 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, General Counsel | Mar 07, 2024 | Option Exercise | $120.49 | 506 | 60,968 | 29,587 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, General Counsel | Mar 08, 2024 | Option Exercise | $123.14 | 899 | 110,703 | 28,688 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 07, 2024 | Option Exercise | $120.49 | 526 | 63,378 | 37,199 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 08, 2024 | Option Exercise | $123.14 | 1,035 | 127,450 | 36,164 | Mar 11, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 04, 2024 | Option Exercise | $125.32 | 1,389 | 174,069 | 37,725 | Mar 06, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mayo Stephen | Director | Mar 05, 2024 | Sale | $122.96 | 3,135 | 385,480 | 6,621 | Mar 06, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, General Counsel | Mar 04, 2024 | Option Exercise | $125.32 | 1,734 | 217,305 | 30,093 | Mar 06, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Mar 04, 2024 | Option Exercise | $125.32 | 522 | 65,417 | 26,437 | Mar 06, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 04, 2024 | Option Exercise | $125.32 | 1,728 | 216,553 | 69,494 | Mar 06, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Mar 01, 2024 | Option Exercise | $126.19 | 365 | 46,059 | 26,722 | Mar 05, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Mar 01, 2024 | Sale | $128.84 | 2,000 | 257,676 | 27,293 | Mar 05, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $126.19 | 365 | 46,059 | 34,314 | Mar 05, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 01, 2024 | Sale | $128.30 | 1,200 | 153,960 | 39,114 | Mar 05, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, General Counsel | Mar 01, 2024 | Sale | $125.34 | 2,000 | 250,680 | 31,827 | Mar 05, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, General Counsel | Mar 01, 2024 | Option Exercise | $126.19 | 269 | 33,945 | 27,827 | Mar 05, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2024 | Option Exercise | $126.19 | 778 | 98,176 | 65,222 | Mar 05, 2024, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Dec 01, 2023 | Option Exercise | $80.34 | 3,682 | 295,812 | 22,886 | Dec 05, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Nov 17, 2023 | Option Exercise | $82.98 | 4,508 | 374,074 | 65,751 | Nov 20, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | Nov 03, 2023 | Buy | $78.81 | 40,000 | 3,152,400 | 140,000 | Nov 06, 2023, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | Nov 03, 2023 | Buy | $78.81 | 10,000 | 788,100 | 10,000 | Nov 06, 2023, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Nov 03, 2023 | Buy | $79.36 | 25,225 | 2,001,800 | 390,307 | Nov 06, 2023, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Director | Nov 03, 2023 | Option Exercise | $29.03 | 15,000 | 435,450 | 174,993 | Nov 06, 2023, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Director | Aug 14, 2023 | Buy | $109.47 | 9,979 | 1,092,429 | 246,996 | Aug 15, 2023, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Director | Aug 11, 2023 | Buy | $108.05 | 23,686 | 2,559,272 | 237,017 | Aug 14, 2023, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Director | Aug 10, 2023 | Buy | $106.15 | 34,867 | 3,701,067 | 213,331 | Aug 11, 2023, 07:40 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Aug 04, 2023 | Sale | $106.72 | 15,000 | 1,600,800 | 20,994 | Aug 08, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Aug 04, 2023 | Option Exercise | $29.03 | 15,000 | 435,450 | 35,994 | Aug 08, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | EVP, General Counsel | Jun 01, 2023 | Option Exercise | $123.60 | 89 | 11,000 | 28,096 | Jun 05, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Mar 30, 2023 | Option Exercise | $136.66 | 307 | 41,955 | 26,367 | Apr 04, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 08, 2023 | Option Exercise | $153.19 | 912 | 139,709 | 70,170 | Mar 10, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 08, 2023 | Option Exercise | $153.19 | 744 | 113,973 | 34,679 | Mar 10, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, General Counsel | Mar 08, 2023 | Option Exercise | $153.19 | 635 | 97,276 | 28,185 | Mar 10, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Mar 08, 2023 | Option Exercise | $153.19 | 314 | 48,102 | 26,674 | Mar 10, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Mar 06, 2023 | Option Exercise | $157.21 | 340 | 53,451 | 22,642 | Mar 08, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 06, 2023 | Option Exercise | $157.21 | 1,370 | 215,378 | 30,923 | Mar 08, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 06, 2023 | Option Exercise | $157.21 | 1,134 | 178,276 | 66,582 | Mar 08, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, General Counsel | Mar 06, 2023 | Option Exercise | $157.21 | 1,325 | 208,303 | 24,491 | Mar 08, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Arif Bilal | Chief Tech Ops Officer | Mar 01, 2023 | Option Exercise | $147.57 | 252 | 37,188 | 22,837 | Mar 03, 2023, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, General Counsel | Mar 01, 2023 | Option Exercise | $147.57 | 196 | 28,924 | 25,645 | Mar 03, 2023, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 01, 2023 | Option Exercise | $147.57 | 378 | 55,781 | 32,293 | Mar 03, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2023 | Option Exercise | $147.57 | 522 | 77,032 | 67,716 | Mar 03, 2023, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Director | Dec 19, 2022 | Option Exercise | $34.92 | 20,000 | 698,400 | 158,470 | Dec 21, 2022, 09:05 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Nov 17, 2022 | Option Exercise | $108.52 | 4,211 | 456,978 | 67,998 | Nov 21, 2022, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mayo Stephen | Director | Nov 17, 2022 | Sale | $109.92 | 858 | 94,311 | 6,387 | Nov 21, 2022, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Director | Sep 14, 2022 | Buy | $104.43 | 57,100 | 5,963,124 | 108,178 | Sep 15, 2022, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Chambers Michael Andrew | Director | Aug 19, 2022 | Buy | $108.28 | 46,170 | 4,999,230 | 51,078 | Aug 22, 2022, 08:30 AM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, General Counsel | Jun 01, 2022 | Option Exercise | $72.67 | 54 | 3,924 | 25,841 | Jun 03, 2022, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 07, 2022 | Option Exercise | $79.36 | 398 | 31,585 | 24,671 | Mar 08, 2022, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 04, 2022 | Option Exercise | $79.20 | 1,308 | 103,594 | 25,069 | Mar 08, 2022, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, General Counsel | Mar 04, 2022 | Option Exercise | $79.20 | 1,136 | 89,971 | 18,048 | Mar 08, 2022, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, General Counsel | Mar 07, 2022 | Option Exercise | $79.36 | 153 | 12,142 | 17,895 | Mar 08, 2022, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Ciambrone William | EVP | Mar 04, 2022 | Option Exercise | $79.20 | 1,160 | 91,872 | 14,099 | Mar 08, 2022, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 04, 2022 | Option Exercise | $79.20 | 1,216 | 96,307 | 64,111 | Mar 08, 2022, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Mar 01, 2022 | Option Exercise | $75.05 | 572 | 42,929 | 65,327 | Mar 01, 2022, 08:03 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 01, 2022 | Option Exercise | $75.05 | 376 | 28,219 | 26,377 | Mar 01, 2022, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, General Counsel | Mar 01, 2022 | Option Exercise | $75.05 | 184 | 13,809 | 19,184 | Mar 01, 2022, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Director | Dec 15, 2021 | Option Exercise | $10.08 | 5,000 | 50,400 | 135,517 | Dec 16, 2021, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Head of R&D, CSO | Nov 24, 2021 | Buy | $79.33 | 3,780 | 299,867 | 65,678 | Nov 29, 2021, 08:00 AM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Nov 17, 2021 | Buy | $79.94 | 25,026 | 2,000,579 | 365,082 | Nov 17, 2021, 06:24 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Sep 08, 2021 | Option Exercise | $78.29 | 1,623 | 127,065 | 26,753 | Sep 09, 2021, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Jun 26, 2021 | Option Exercise | $80.40 | 17,812 | 1,432,085 | 340,056 | Jun 28, 2021, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Director | Mar 10, 2021 | Option Exercise | $42.30 | 5,000 | 211,500 | 135,517 | Mar 10, 2021, 08:04 PM | |
| SRPT | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN | Director | Mar 10, 2021 | Sale | $85.76 | 5,000 | 428,800 | 130,517 | Mar 10, 2021, 08:04 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Mar 08, 2021 | Option Exercise | $34.92 | 10,000 | 349,200 | 26,518 | Mar 10, 2021, 08:03 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Mar 08, 2021 | Sale | $83.51 | 10,000 | 835,100 | 16,518 | Mar 10, 2021, 08:03 PM | |
| SRPT | Sarepta Therapeutics, Inc. | O'Neill Gilmore Neil | EVP, R&D & CMO | Feb 28, 2021 | Option Exercise | $86.97 | 524 | 45,572 | 13,546 | Mar 10, 2021, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, General Counsel | Feb 28, 2021 | Option Exercise | $86.97 | 216 | 18,786 | 4,622 | Mar 10, 2021, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Brown Ryan Edward | SVP, General Counsel | Mar 04, 2021 | Option Exercise | $80.76 | 190 | 15,344 | 19,432 | Mar 10, 2021, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise | Chief Scientific Officer | Feb 28, 2021 | Option Exercise | $86.97 | 565 | 49,138 | 6,604 | Mar 10, 2021, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Feb 28, 2021 | Option Exercise | $86.97 | 319 | 27,743 | 13,723 | Mar 10, 2021, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Estepan Ian Michael | Chief Financial Officer | Mar 05, 2021 | Option Exercise | $84.65 | 347 | 29,374 | 28,376 | Mar 10, 2021, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Dec 31, 2020 | Option Exercise | $170.49 | 37,144 | 6,332,681 | 357,868 | Jan 04, 2021, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Bratica Joseph | Principal Financial Officer | Dec 11, 2020 | Option Exercise | $71.45 | 1,115 | 79,667 | 9,255 | Dec 14, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Bratica Joseph | Principal Financial Officer | Dec 11, 2020 | Sale | $165.00 | 1,115 | 183,975 | 8,140 | Dec 14, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Bratica Joseph | Principal Financial Officer | Dec 08, 2020 | Option Exercise | $29.60 | 1,125 | 33,300 | 9,265 | Dec 10, 2020, 08:23 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Bratica Joseph | Principal Financial Officer | Dec 08, 2020 | Sale | $160.00 | 1,125 | 180,000 | 8,140 | Dec 10, 2020, 08:23 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Aug 10, 2020 | Option Exercise | $34.92 | 10,000 | 349,200 | 23,792 | Aug 11, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Aug 10, 2020 | Sale | $159.00 | 10,000 | 1,590,044 | 14,569 | Aug 11, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | Aug 07, 2020 | Sale | $158.50 | 30,000 | 4,754,972 | 3,132,280 | Aug 07, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Bratica Joseph | Principal Financial Officer | Aug 03, 2020 | Option Exercise | $29.60 | 1,125 | 33,300 | 8,957 | Aug 05, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Bratica Joseph | Principal Financial Officer | Aug 03, 2020 | Sale | $155.00 | 1,125 | 174,375 | 7,832 | Aug 05, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Mahatme Sandesh | EVP, CFO & CBO | Jul 08, 2020 | Option Exercise | $19.69 | 3,806 | 74,941 | 20,260 | Jul 09, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Jun 22, 2020 | Option Exercise | $25.76 | 105,122 | 2,708,440 | 136,993 | Jun 22, 2020, 09:17 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Howton David T | EVP, General Counsel | Jun 22, 2020 | Sale | $170.88 | 105,122 | 17,962,831 | 130,984 | Jun 22, 2020, 09:17 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | May 20, 2020 | Option Exercise | $10.08 | 5,000 | 50,400 | 18,792 | May 22, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | May 20, 2020 | Sale | $150.64 | 5,000 | 753,210 | 16,692 | May 22, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Barry Richard | Director | May 15, 2020 | Sale | $141.26 | 30,000 | 4,237,946 | 3,163,813 | May 15, 2020, 09:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Mar 04, 2020 | Option Exercise | $8.46 | 5,000 | 42,300 | 18,792 | Mar 06, 2020, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Wigzell Hans Lennart Rudolf | Director | Mar 04, 2020 | Sale | $116.89 | 5,000 | 584,450 | 13,792 | Mar 06, 2020, 08:01 PM | |
| SRPT | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S | President & CEO | Dec 31, 2019 | Option Exercise | $129.04 | 37,185 | 4,798,352 | 395,012 | Jan 03, 2020, 08:00 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | EVP, Chief Commercial Officer | Dec 13, 2019 | Sale | $125.50 | 42,000 | 5,271,000 | 11,161 | Dec 17, 2019, 08:02 PM | |
| SRPT | Sarepta Therapeutics, Inc. | Cumbo Alexander | EVP, Chief Commercial Officer | Dec 13, 2019 | Option Exercise | $23.70 | 32,706 | 775,232 | 43,867 | Dec 17, 2019, 08:02 PM |
Menu